After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Stoke Therapeutics Inc is $448.30M. A total of 0.96 million shares were traded on the day, compared to an average of 835.87K shares.
In the most recent transaction, Kaye Edward M. MD sold 10,382 shares of STOK for 8.67 per share on Mar 18 ’25. After the transaction, the Director now owns 148,253 company shares. In a previous transaction on Mar 19 ’25, Kaye Edward M. MD sold 8,907 shares at 8.27 per share. STOK shares that Director owns now total 139,346.
Among the insiders who sold shares, Ticho Barry disposed of 3,884 shares on Mar 18 ’25 at a per-share price of $8.67. This resulted in the CHIEF MEDICAL OFFICER holding 63,962 shares of STOK after the transaction. In another insider transaction, Ticho Barry sold 3,333 shares at $8.27 per share on Mar 19 ’25. Company shares held by the CHIEF MEDICAL OFFICER now total 60,629.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, STOK has a high of $17.58 and a low of $5.93.
As of this writing, STOK has an earnings estimate of -$0.07 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of $1.87 per share and a lower estimate of -$0.53.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. STOK’s latest balance sheet shows that the firm has $219.81M in Cash & Short Term Investments as of fiscal 2021. There were $1.51M in debt and $17.14M in liabilities at the time. Its Book Value Per Share was $4.24, while its Total Shareholder’s Equity was $217.78M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for STOK is Buy with a score of 4.70.
